c diff quik chek complete immunochromatographic test kit (Abbott Laboratories)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Abbott Laboratories c diff quik chek complete immunochromatographic test kit
C Diff Quik Chek Complete Immunochromatographic Test Kit, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/diff+quik+kit/c+chek+complete+diff+quik/pmc12719486-74-17-25
Average 86 stars, based on 1 article reviews

c diff quik chek complete immunochromatographic test kit - by Bioz Stars, 2026-09

86/100 stars

Images

Diagnostic Assay:

Article Title: Geriatric nutritional risk index as a risk-factor for Clostridioides difficile infection relapse in elderly Japanese patients
Article Snippet: .. The diagnostic criteria for CDI were as follows: glutamate dehydrogenase antigen and toxin A/B were positive using a detection kit (C. DIFF QUIK CHEK COMPLETE ® , Abbott Diagnostics Medical Co., Tokyo, Japan), and toxin A/B was negative using the kit, but the toxin B gene was positive using the nucleic acid amplification test. ..

Diff-Quik:

Article Title: Multi-drug resistant Clostridioides difficile isolate ST81 is prominent in hematological patients in a teaching hospital in China
Article Snippet: .. Glutamate dehydrogenase (GDH) assays and toxins A/B (TcdA/B) assays were performed on patient stool specimens using the C. DIFF QUIK CHEK COMPLETE immunochromatographic test kit (Alere, USA). .. Stools that tested positive for GDH were subsequently inoculated for 48 hours at 37 °C in an anaerobic environment with C. difficile CDIF selective medium (BioMerieux, France).

Amplification:

other:

Article Title: Diagnosis of Clostridium difficile Infections in Children
Article Snippet: Additional FDA-cleared assays have not been evaluated exclusively in pediatric patients (Focus Diagnostics Simplexa, Great Basin Portrait, Verigene, IMDx Abbott m2000, and Primera ICEPlex). b PPV, positive predictive value. c NPV, negative predictive value. d Toxigenic culture was defined by the authors as growth on cycloserine cefoxitin fructose agar (CCFA) or Cdiff CHROMagar (bioMérieux, France) confirmed with toxin gene PCR. e Composite standard defined by the authors as a positive result for both Meridian illumigene and positive by another enzyme immunoassay. f C. Diff Quik Chek Complete kit (Alere GmBH, Kolm, Germany) and DNA hybridization assay (Hain Lifescience GmBH, Nehren, Germany). g NA, nonapplicable.

Article Title: Coinfection and Emergence of Rifamycin Resistance during a Recurrent Clostridium difficile Infection
Article Snippet: However, within 10 days he suffered another diarrheal episode ( , sample D), which was initially toxin negative as confirmed using the C. Diff Quik Chek complete kit (Alere) and PCR using the BD MAX Cdiff kit (BD Molecular Diagnostics).

Article Title: Coinfection and Emergence of Rifamycin Resistance during a Recurrent Clostridium difficile Infection
Article Snippet: These included diagnostic specimens from the Queens Medical Centre (QMC) microbiology department, Nottingham, that were proven C. difficile toxin positive by using the C. Diff Quik Chek complete kit (Alere) and PCR using the BD MAX Cdiff kit (BD Molecular Diagnostics).

Article Title: Detection of Clostridioides difficile toxin B gene in clinical stool specimens using rapid diagnostic quenching probe-polymerase chain reaction assay.
Article Snippet: We tested the accuracy of quenching probe-polymerase chain reaction (QP-PCR) for detecting Clostridioides difficile toxin B gene (tcdB) in stools from inpatients with suspected C. difficile infection and compared the results with other nucleic acid amplification tests (NAATs).. Toxigenic culture results were used as reference for comparison.. QP-PCR had comparable diagnostic accuracy with other NAATs and prior bead-beating enabled detection of tcdB in specimens judged as negative, without bead-beating.

Article Title: Standardisation and validation of an in-house quantitative real-time polymerase chain reaction (qPCR) assay for the diagnosis of Clostridioides difficile infection.
Article Snippet: Objectives: Clostridioides difficile is an emerging enteric pathogen that causes nosocomial diarrhoea in adults.. The excessive cost of commercial molecular tests restricts the access of developing countries to its diagnosis.. This study aimed to develop and validate in-house quantitative polymerase chain reaction (qPCR) targeting the C. difficile toxin B gene (tcdB) using two detection methodologies—SYBR Green and hydrolysis probes—for the diagnosis of C. difficile infection (CDI).

Review